The Cancer Outcomes Measurement Working Group: Rationale overview and a look to the future

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 6, Issue 4, 2006, Pages 407-416

  Snyder, Claire ^a   Gotay, Carolyn C ^b   Lipscomb, Joseph ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Cancer; Economics; Quality of life; Satisfaction

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER SCREENING; CANCER SURVIVAL; CAREGIVER; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DOCTOR PATIENT RELATION; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; LUNG CANCER; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PATIENT SATISFACTION; PROSTATE CANCER; PSYCHOMETRY; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 33748140662     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.6.4.407     Document Type: Review

References (5)

1. American Cancer Society. Cancer Facts & Figures 2006. American Cancer Society, GA, USA (2006).
2. Lipscomb J, Gotay CC, Snyder C (Eds.). Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge University Press, Cambridge, UK, (2005).
3. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 11, 193-205 (2002).
4. Gotay CC, Lipscomb J, Snyder CF. Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase. J Natl Cancer Inst. 97, 1568-1574 (2005).
5. Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims. Draft Guidance for Industry US FDA, MD, US (2006).